The largest database of trusted experimental protocols

3 protocols using anti ccr3

1

Multicolor Flow Cytometry Panel for Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained with the following fluorochrome-conjugated antibodies: anti-B220 (eBioscience, clone RA3-6B2), anti-CD3e (eBioscience, clone 145-2C11), anti-CD8a (BD, clone 53-6.7), anti-CD11b (eBioscience, clone M1/70), anti-CD11c (Bio Legend, clone N418), anti-CD14 (Bio Legend, clone SA14-2), anti-CD19 (eBioscience, clone eBio1D3), anti-CD64 (Bio Legend, clone X54-5/7.1), anti-CD68 (AbD Serotec, clone FA-11), anti-CD163 (Bioss, polyclonal), anti-CD115 (eBioscience, clone AF598), anti-CCR3 (Bio Legend, clone J073E5), anti-F4/80 (Bio Legend, clone CI:A3-1), anti-FPR-1 (Bioss, polyclonal), anti-MHC II (Bio Legend, clone M5/114.15.2), anti-MR (AbD Serotec, clone MR5D3) and anti-PILRa (R&D Systems, polyclonal). Fc receptors were blocked with 1.5mg/ml human IgG (Privigen). Dead cells were excluded using the Hoechst 33342 dye. Only events that appeared single in forward-scatter width were analyzed. The gating strategy is shown in Supplementary Figure 7. A FACSCanto II and FACSDiva software (BD) were used for flow cytometry and data were analyzed with FlowJo software (TreeStar).
+ Open protocol
+ Expand
2

Isolation and Characterization of Microglia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microglia cells were isolated through Percoll gradient or Miltenyi Adult Brain Dissociation kit, as described in RNA‐Seq Analysis. Microglia staining occurred in 1X dPBS−/− (Thermo Fischer) supplemented with 0.5% FBS, 0.4% 0.5 M EDTA, and 1% HEPES at 4°C for 20 min. Cells were stained with the following antibodies: anti‐CD11b (clone:M1/70, eBioscience), anti‐CD45 (clone:30‐F11, eBioscience), anti‐F480 (clone:BM8, eBiosience), anti‐CX3CR1 (clone:SA011F11, Biolegend), anti‐CD31 (clone:MEC13.3, Biolegend), anti‐CCR3 (clone:J073E5, Biolegend), anti‐ I‐A/I‐E (clone:M5/114.15.2, Biolegend), anti‐CD80 (clone:16‐10A1, eBioscience), anti‐CD86 (clone:GL1, eBioscience), and anti‐TLR4 (clone:SA15‐21, Biolegend). Following staining, cells were washed twice and fixed in a 1:1 solution of supplemented dPBS−/−: 4% paraformaldehyde overnight at 4°C. After fixation, cells were resuspended in supplemented dPBS−/−and enumerated via flow cytometry (BD LSR II with 561 laser). Microglia populations were identified as CD11bhigh/CD45low. Subsequent data was analyzed using FlowJo software (v. 10.5.3).
+ Open protocol
+ Expand
3

Basophil Activation Assay for Allergen Reactivity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Basophil activation tests were performed as previously described. 28 Briefly, titrated amounts of recombinant allergens or apple extract (0.25-100 ng/mL) in HEPES calcium buffer (pH 7.4) supplemented with IL-3 (2 ng/mL) were added to heparinized whole blood from 4 untreated subjects with BPRAA who displayed rMal d 1-specific IgE levels of 1.1, 1.4, 2.6, and 5.8 kU A /L, respectively. As a negative control, blood was stimulated with HEPES/IL-3 to confirm that basophils were not activated nonspecifically. After incubation for 15 minutes at 378C the reaction was stopped with HEPES/EDTA (20 mmol/L) buffer and cells were stained with anti-CCR3 (allophycocyanin), anti-CD123 (peridinin-chlorophyllprotein), and anti-CD63 (phycoerythrin) (all from BioLegend, San Diego, Calif). After lysis of erythrocytes, basophils were defined as CD123 1 CCR3 1 cells by using BD FACSCanto II and BD FACSDiva software (version 6.1.3) (BD Pharmingen, San Jose, Calif). The concentration of allergen that induced approximately 40% to 50% of CD63 1 basophils in reference to untreated cells was incubated with the indicated pre-and post-SLIT serum samples for 1 hour at 378C before addition to heparinized whole blood of the respective individual.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!